Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET)
1 clinical trials · Condition
◉ Watch Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET)
| Record | Firm | Date |
|---|---|---|
| Study to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NET (NCT06784752) | Novartis Pharmaceuticals | 2025-05-30 |
Track Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET) automatically
Every clearance here is in the API, with alerts when new ones post.